Nisa Investment Advisors
VYGR icon

Nisa Investment Advisors’s Voyager Therapeutics VYGR Stock Holding History

Nisa Investment Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69K Hold
437
– – ﹤0.01% 2648
2025
Q4 		$1.72K Hold
437
– – ﹤0.01% 2632
2025
Q3 		$2.04K Buy
+437
New +$1.58K ﹤0.01% 2612
2025
Q2 		– Sell
-508
Closed -$1.72K – 3100
2025
Q1 		$1.72K Buy
508
+76
+18% +$355 ﹤0.01% 2507
2024
Q4 		$2.45K Buy
432
+150
+53% +$967 ﹤0.01% 2429
2024
Q3 		$1.65K Buy
282
+164
+139% +$1.19K ﹤0.01% 2447
2024
Q2 		$933 Buy
118
+85
+258% +$713 ﹤0.01% 2533
2024
Q1 		$307 Buy
+33
New +$279 ﹤0.01% 2578
2020
Q1 		– Sell
-10,200
Closed -$142K – 2137
2019
Q4 		$142K Hold
10,200
– – ﹤0.01% 1379
2019
Q3 		$176K Hold
10,200
– – ﹤0.01% 1354
2019
Q2 		$278K Hold
10,200
– – ﹤0.01% 1253
2019
Q1 		$195K Sell
10,200
-2,600
-20% -$33.9K ﹤0.01% 1316
2018
Q4 		$120K Buy
12,800
+2,500
+24% +$32.1K ﹤0.01% 1343
2018
Q3 		$195K Hold
10,300
– – ﹤0.01% 1326
2018
Q2 		$201K Hold
10,300
– – ﹤0.01% 1261
2018
Q1 		$194K Hold
10,300
– – ﹤0.01% 1246
2017
Q4 		$171K Hold
10,300
– – ﹤0.01% 1299
2017
Q3 		$212K Buy
+10,300
New +$116K ﹤0.01% 1236

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nisa Investment Advisors's VYGR Position: Q1 2026 in Review

Nisa Investment Advisors held its Voyager Therapeutics (VYGR) position steady in Q1 2026 at 437 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

Nisa Investment Advisors first reported a position in VYGR in Q3 2017 and has held it in 18 quarters since. The position peaked at $278K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Nisa Investment Advisors held 437 shares of Voyager Therapeutics worth $1.69K as of Q1 2026.
  • Nisa Investment Advisors left its Voyager Therapeutics share count unchanged in Q1 2026.
  • Voyager Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2648 holding.
  • Nisa Investment Advisors first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 18 quarters since.
  • Nisa Investment Advisors's Voyager Therapeutics position peaked at $278K in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.